MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-31-2026
LENSAR Operating Income 2011-2026 | LNSR
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income LENSAR
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -24.6 M | -10.7 M | -12.2 M | -20.2 M | -19.7 M | -18.5 M | -12.7 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -10.7 M | -24.6 M | -16.9 M |
Quarterly Operating Income LENSAR
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.58 M | -6.29 M | -5.79 M | - | -1.24 M | -5.28 M | -2.85 M | - | -2.04 M | -2.87 M | -4.36 M | - | -4.08 M | -6.8 M | -6.68 M | - | -6.16 M | -4.38 M | -5.2 M | - | -4.71 M | -3.84 M | -3.1 M | - | -5.34 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -1.24 M | -7.58 M | -4.66 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ClearPoint Neuro
CLPT
|
-24.2 M | $ 11.1 | -0.72 % | $ 314 M |  USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Electromed
ELMD
|
9.66 M | $ 25.81 | 0.98 % | $ 218 M | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 2.16 | - | $ 1.31 M | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Second Sight Medical Products
EYES
|
-27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.45 | 3.29 % | $ 129 M |  France |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-14.7 M | $ 0.61 | -2.42 % | $ 38 M | USA |
 |
Delcath Systems
DCTH
|
660 K | $ 11.53 | 4.63 % | $ 413 M | USA |
 |
BioSig Technologies
BSGM
|
-71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
LivaNova PLC
LIVN
|
199 M | $ 57.59 | -2.51 % | $ 3.14 B |  Britain |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
Insulet Corporation
PODD
|
474 M | $ 167.53 | -2.25 % | $ 11.8 B | USA |
 |
Inspire Medical Systems
INSP
|
51 M | $ 48.25 | -12.02 % | $ 1.42 B | USA |
 |
IRIDEX Corporation
IRIX
|
-2.57 M | $ 1.05 | -3.23 % | $ 17.8 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Sintx Technologies
SINT
|
-10.7 M | $ 2.42 | - | $ 6.71 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 17.04 | 7.98 % | $ 400 M | USA |
 |
Butterfly Network
BFLY
|
-74.4 M | $ 4.82 | -0.52 % | $ 1.02 B | USA |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
TransMedics Group
TMDX
|
109 M | $ 94.93 | -2.21 % | $ 3.23 B | USA |
 |
Tandem Diabetes Care
TNDM
|
8.29 M | $ 19.42 | -2.26 % | $ 1.32 B | USA |
 |
Globus Medical
GMED
|
480 M | $ 90.03 | -0.63 % | $ 12.2 B | USA |
 |
NanoVibronix
NAOV
|
-22.9 M | - | - | $ 1.08 M | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 36.64 | 2.12 % | $ 1.14 B | USA |
 |
Stryker Corporation
SYK
|
4.89 B | $ 295.25 | 1.5 % | $ 113 B | USA |
 |
Integer Holdings Corporation
ITGR
|
221 M | $ 85.85 | 2.26 % | $ 2.98 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.26 B | $ 82.91 | -0.5 % | $ 48.5 B | USA |
 |
Pulmonx Corporation
LUNG
|
-53.7 M | $ 1.27 | -4.51 % | $ 51.7 M | USA |
 |
MiMedx Group
MDXG
|
63.9 M | $ 3.64 | 0.83 % | $ 538 M | USA |
 |
Myomo
MYO
|
-14.4 M | $ 0.88 | 1.69 % | $ 36.8 M | USA |